This course will be held at the Medway Campus
The Medway School of Pharmacy’s innovative postgraduate distance-learning programme in Medicines Management equips healthcare professionals with the skills and knowledge to contribute effectively to medicines management services and to individual drug therapy decisions.
The programme emphasises clinical and costeffective prescribing in the context of holistic consideration of patient needs, and one of its pathways offers you the chance to qualify as an independent/supplementary prescriber.
Visit the website https://www.kent.ac.uk/courses/postgraduate/738/medicines-management
About Medway School of Pharmacy
Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent
and the University of Greenwich.
The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.
The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.
You can register for the full MSc programme or undertake stand-alone modules. Modules can be put together to form a short course programme. Module length varies from five to 15 credits.
For the PCert, you must complete 60 credits, of which at least 20 must be from core modules. Diploma students must complete 120 credits, of which at least 40 credits must be from core modules. To gain the MSc, you must complete a 60-credit research project, write a dissertation and present the results as a poster.
The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.
Assessment includes case study analysis, critical appraisal of literature, assignments including short essays, a research project and dissertation.
This programme aims to:
- equip healthcare professionals with the skills and knowledge to contribute effectively to medicines management services and to individual drug therapy decisions in primary and secondary care.
- enable you to incorporate your learning directly into your workplace and to rise to the challenges presented by the new, patient-centred NHS.
- Chemistry and drug delivery
This group has laboratories with dedicated state-ofthe art drug delivery, nanotechnology, spectroscopy, chromatography and organic synthesis facilities. It brings together researchers in medicinal chemistry and drug design, nanotechnology and materials science, drug delivery and pharmaceutics encouraging a multidisciplinary approach to research. Research covers synthesis and biological evaluation of potential anti-cancer agents, structurebased drug design, QSAR predication of ADMET properties, controlled release, particle engineering, powder technology, pharmaceutical technology, and novel drug delivery systems, with a focus on respiratory drug delivery.
- Biological sciences
This group is housed in recently refurbished laboratories with dedicated state-of-the-art molecular biological, electrophysiological, tissue culture and microscopy facilities. The research is divided into four main themes; infectious diseases and allergy; neuroscience; renal and cardiovascular physiology; and pharmacology. Examples of current work include: investigation of the use of non-pathogenic virus ‘pseudotypes’ to study pathogenic RNA, study of the properties of neuronal potassium channels and their modulation and the development of new therapies for patients that have developed acute kidney injury in collaboration with a major pharmaceutical company.
- Pharmacy practice
This group conducts research in two areas: public health and medicines optimisation, with a particular focus on cardiovascular diseases and mental health. Work in public health includes studies in physical exercise, alcohol, cardiovascular screening and spirometry testing, plus pharmacovigilance. Studies in medicines optimisation include work in dementia, bipolar disorder and stroke, with an emphasis on the patient perspective.
Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.
The taught postgraduate programmes are designed to promote the continuing professional development by providing sought-after skills. The programmes are beneficial for those who wish to develop their skills and/or to take the next step in their career.
Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply/
A first degree in a relevant subject from an EU university; equivalent qualifications from a non-EU university may be acceptable but their comparability will be assessed on an individual basis; or at least five years of working experience in health care after obtaining a relevant professional qualification. Students must also be registered with the relevant UK professional body and practising in the UK, preferably within the National Health Service.